GB1499751A - Pharmaceutical preparation - Google Patents

Pharmaceutical preparation

Info

Publication number
GB1499751A
GB1499751A GB4193/75A GB419375A GB1499751A GB 1499751 A GB1499751 A GB 1499751A GB 4193/75 A GB4193/75 A GB 4193/75A GB 419375 A GB419375 A GB 419375A GB 1499751 A GB1499751 A GB 1499751A
Authority
GB
United Kingdom
Prior art keywords
acetyl
poly
glucosamine
glucosamines
matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4193/75A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of GB1499751A publication Critical patent/GB1499751A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB4193/75A 1974-02-11 1975-01-30 Pharmaceutical preparation Expired GB1499751A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US441695A US3911098A (en) 1974-02-11 1974-02-11 Medicament carrier

Publications (1)

Publication Number Publication Date
GB1499751A true GB1499751A (en) 1978-02-01

Family

ID=23753927

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4193/75A Expired GB1499751A (en) 1974-02-11 1975-01-30 Pharmaceutical preparation

Country Status (19)

Country Link
US (1) US3911098A (xx)
JP (1) JPS50123815A (xx)
AR (1) AR206618A1 (xx)
BE (1) BE825367A (xx)
CA (1) CA1045975A (xx)
CS (1) CS207808B1 (xx)
DD (1) DD118801A5 (xx)
DE (1) DE2505305A1 (xx)
ES (1) ES434618A1 (xx)
FR (1) FR2260356B1 (xx)
GB (1) GB1499751A (xx)
IL (1) IL46496A (xx)
IT (1) IT1036866B (xx)
NL (1) NL7501365A (xx)
PH (1) PH13485A (xx)
PL (1) PL177948A1 (xx)
RO (1) RO68711A (xx)
SE (1) SE7501464L (xx)
ZA (1) ZA75472B (xx)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0086627A1 (en) * 1982-02-12 1983-08-24 Unitika Ltd. Anti-cancer device
US6174299B1 (en) 1991-09-09 2001-01-16 Harvey B. Pollard Method for treating hemophilia A and B and AIDS and devices used therein

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL188266C (nl) * 1975-07-29 1992-05-18 Merck & Co Inc Werkwijze ter bereiding van een oogheelkundig inplantaat.
US4066747A (en) * 1976-04-08 1978-01-03 Alza Corporation Polymeric orthoesters housing beneficial drug for controlled release therefrom
DE2861226D1 (en) * 1977-06-28 1981-12-10 Univ Strathclyde A pharmaceutical composition for tropical diseases
US4287175A (en) * 1978-06-22 1981-09-01 Merck & Co., Inc. Contact lens wetting agents
JPS57134412A (en) * 1981-02-12 1982-08-19 Unitika Ltd Biodegradable drug donor
US5277900A (en) * 1982-08-07 1994-01-11 Henkel Kommanditgesellschaft Auf Aktien Method for blood coagulation on hard tissues
JPS6036410A (ja) * 1983-08-08 1985-02-25 Unitika Ltd 生分解性薬物供与体の製造方法
US5290752A (en) * 1984-03-16 1994-03-01 Unitika Ltd. Method for preparation of a shaped chitin body containing a physiologically active substance
JPH0623091B2 (ja) * 1984-03-16 1994-03-30 ユニチカ株式会社 キチン成形体の製造法
JPS62193638A (ja) * 1986-02-20 1987-08-25 Kao Corp 顆粒剤
US4931551A (en) * 1988-07-05 1990-06-05 University Of Delaware Dispersions of chitin and product therefrom
US5383873A (en) * 1992-12-09 1995-01-24 Regents Of The University Of Minnesota Smooth muscle chemical pacemaker
US5741329A (en) * 1994-12-21 1998-04-21 Board Of Regents, The University Of Texas System Method of controlling the pH in the vicinity of biodegradable implants
US6065476A (en) * 1994-12-21 2000-05-23 Board Of Regents, University Of Texas System Method of enhancing surface porosity of biodegradable implants
US6767899B1 (en) 2000-08-29 2004-07-27 Leiner Health Services Corp. Composition and method for treatment of conditions having an inflammatory component
US7018646B2 (en) * 2002-05-30 2006-03-28 Van Dalen Johan T W Apparatus and method for delivering controlled quantities of one or more agents to the eye
US7785291B2 (en) * 2005-03-01 2010-08-31 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
US7699863B2 (en) * 2005-03-01 2010-04-20 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
DK2858604T3 (da) 2012-06-07 2024-05-21 Epitomee Medical Ltd Ekspanderet anordning
US9320645B2 (en) 2013-05-29 2016-04-26 Terry Glasser Approach to administering ocular medication
EP3091962B1 (en) 2013-12-05 2022-06-08 Epitomee Medical Ltd. Retentive devices and systems for in-situ release of pharmaceutical active agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2040879A (en) * 1934-06-21 1936-05-19 Du Pont Substantially undegraded deacetylated chitin and process for producing the same
US2040880A (en) * 1934-06-21 1936-05-19 Du Pont Process for the preparation of films and filaments and products thereof
US2168374A (en) * 1936-07-09 1939-08-08 Visking Corp Chemical compounds and products produced therefrom
US3632754A (en) * 1968-02-12 1972-01-04 Lescarden Ltd Use of chitin for promoting wound healing
US3736646A (en) * 1971-10-18 1973-06-05 American Cyanamid Co Method of attaching surgical needles to multifilament polyglycolic acid absorbable sutures
US3845201A (en) * 1972-04-24 1974-10-29 S Loucas Solid state ophthalmic medication delivery method

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0086627A1 (en) * 1982-02-12 1983-08-24 Unitika Ltd. Anti-cancer device
US6174299B1 (en) 1991-09-09 2001-01-16 Harvey B. Pollard Method for treating hemophilia A and B and AIDS and devices used therein

Also Published As

Publication number Publication date
AR206618A1 (es) 1976-08-06
RO68711A (ro) 1980-10-30
IL46496A (en) 1978-08-31
CA1045975A (en) 1979-01-09
BE825367A (fr) 1975-08-11
DD118801A5 (xx) 1976-03-20
AU7760275A (en) 1976-07-29
PL177948A1 (en) 1978-04-10
FR2260356B1 (xx) 1978-07-28
NL7501365A (nl) 1975-08-13
US3911098A (en) 1975-10-07
DE2505305A1 (de) 1975-08-21
IL46496A0 (en) 1975-06-25
FR2260356A1 (xx) 1975-09-05
ZA75472B (en) 1976-01-28
JPS50123815A (xx) 1975-09-29
CS207808B1 (en) 1981-08-31
PH13485A (en) 1980-05-21
SE7501464L (xx) 1975-08-12
ES434618A1 (es) 1977-04-16
IT1036866B (it) 1979-10-30

Similar Documents

Publication Publication Date Title
GB1499751A (en) Pharmaceutical preparation
NZ295211A (en) Topical aqueous gel containing a water-soluble cellulose derivative, propylene glycol & drug(s) for haemorrhoids
ES2172242T3 (es) Composiciones oftalmicas de liberacion mantenida conteniendo medicamentos solubles en agua.
KR870002832A (ko) 제약 조성물
GB2040680A (en) Pharmaceutical vehicle
AU6786187A (en) Pharmaceutical preparation for obtaining a highly viscose hydrogel or suspension
NZ223989A (en) Contraceptive compositions comprising melatonin and a progestogen or an estrogen or both
IE870993L (en) Nasal administration compositions.
CA2067228A1 (en) Drug delivery system, method for preparing the same and use thereof
CA2170748A1 (en) Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
HUP9801414A2 (hu) Nátrium-alginátot és kálium-bikarbonátot tartalmazó folyékony vizes gyógyszerkészítmények
CA2231176A1 (en) Long active composition for rectal administration
FR2407262A1 (fr) Nouveaux polysaccharides extraits de corps microbiens d'haemophilus influenzae, procede de preparation et application a titre de medicaments de ces nouveaux produits
DE3373417D1 (en) Use of a sulfonated homo- or copolymer of styrene for the manufacture of a contraceptive composition
EP0873751A3 (en) Pharmaceutical product for application to uterus mucosa
FR2332999A1 (fr) Derives d'oestradiol, leur preparation et leur application comme medicaments antioestrogenes
GR3017161T3 (en) Multi-fractionable tablet structure.
GEP20043254B (en) Use of Camptothecin Derivatives with Reduced Gastrointestinal Toxicity
Buttram Jr Cyclic use of combination oral contraceptives and the severity of endometriosis
EP0343631A3 (en) Preventing agent for human immunodeficiency virus infection comprising menfegol
IE781117L (en) Medicament comprising erythromycin and metoclopramide
EP0391852A3 (en) Pharmaceutical compositions
GB1315458A (en) Nucleobase-containing gels
AP1707A (en) Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same.
AU671651B2 (en) A drug delivery device and a method of making such device

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee